SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2vgq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	VAL A 8 VAL A 50 ILE A 60 ASN A 267	None	0.94A	1e06A-2vgqA: undetectable	1e06A-2vgqA: 15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOH_C_FRDC305_2 (POL POLYPROTEIN PEPTIDE INHIBITOR)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	LEU A 262 GLY A 289 ALA A 109 ILE A 108	None	0.86A	2aohB-2vgqA: undetectable	2aohB-2vgqA: 13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	ALA A 264 LEU A 280 PHE A 279 VAL A 293 GLY A 16	None	1.09A	2ve3A-2vgqA: undetectable	2ve3A-2vgqA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_A_SAMA801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	THR A 93 LEU A 285 ASP A 287 GLU A 111	None None None MTT A1463 (-2.9A)	1.02A	2zw9A-2vgqA: undetectable	2zw9A-2vgqA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A35_A_RBFA191_1 (LUMAZINE PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A 192 THR A 193 ALA A 346 THR A 345 ILE A 348	None	1.21A	3a35A-2vgqA: undetectable	3a35A-2vgqA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A35_B_RBFB191_1 (LUMAZINE PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A 192 THR A 193 ALA A 346 THR A 345 ILE A 348	None	1.22A	3a35B-2vgqA: undetectable	3a35B-2vgqA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A3B_A_RBFA191_1 (LUMAZINE PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A 192 THR A 193 ALA A 346 THR A 345 ILE A 348	None	1.23A	3a3bA-2vgqA: undetectable	3a3bA-2vgqA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	PHE A 258 ALA A 162 LEU A 247 PRO A 159	None	0.92A	3bgdA-2vgqA: undetectable	3bgdA-2vgqA: 20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 7	VAL A 110 GLY A 300 PRO A 229 LYS A 305	None	0.72A	3bjwC-2vgqA: undetectable	3bjwC-2vgqA: 13.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	12 / 12	ASP A 14 LYS A 15 LYS A 42 GLU A 44 GLU A 45 ALA A 63 ASP A 65 ARG A 66 GLU A 111 PRO A 154 TRP A 230 TYR A 341	MTT A1463 (-2.9A) MTT A1463 (-2.7A) MTT A1463 (-4.3A) MTT A1463 (-3.1A) MTT A1463 (-3.5A) MTT A1463 (-3.2A) MTT A1463 (-2.8A) MTT A1463 (-3.7A) MTT A1463 (-2.9A) MTT A1463 (-3.5A) MTT A1463 (-4.4A) MTT A1463 (-4.5A)	0.23A	3jyrA-2vgqA: 63.1	3jyrA-2vgqA: 79.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	7 / 7	ASN A 12 TRP A 62 GLU A 153 TYR A 155 MET A 330 TRP A 340 ARG A 344	MTT A1463 ( 4.8A) MTT A1463 (-4.2A) MTT A1463 (-3.1A) MTT A1463 (-3.7A) MTT A1463 ( 4.4A) MTT A1463 (-3.9A) MTT A1463 (-3.5A)	0.14A	3jyrA-2vgqA: 63.1	3jyrA-2vgqA: 79.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	VAL A 196 LEU A 160 GLY A 187 ALA A 188 LEU A 361	None	1.00A	3n8yB-2vgqA: undetectable	3n8yB-2vgqA: 20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	PHE A 156 GLY A 300 LEU A 299 GLU A 111 ALA A 231	MTT A1463 (-4.9A) None None MTT A1463 (-2.9A) None	0.85A	3tbgB-2vgqA: undetectable	3tbgB-2vgqA: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	PHE A 156 GLY A 300 LEU A 299 GLU A 111 ALA A 231	MTT A1463 (-4.9A) None None MTT A1463 (-2.9A) None	0.84A	3tbgD-2vgqA: undetectable	3tbgD-2vgqA: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U5K_A_08JA1_1 (BROMODOMAIN-CONTAINI NG PROTEIN 4)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.69A	3u5kA-2vgqA: undetectable	3u5kA-2vgqA: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U5K_B_08JB2_1 (BROMODOMAIN-CONTAINI NG PROTEIN 4)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 7	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.54A	3u5kB-2vgqA: undetectable	3u5kB-2vgqA: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U5K_C_08JC3_1 (BROMODOMAIN-CONTAINI NG PROTEIN 4)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.64A	3u5kC-2vgqA: undetectable	3u5kC-2vgqA: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U5K_D_08JD4_1 (BROMODOMAIN-CONTAINI NG PROTEIN 4)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.72A	3u5kD-2vgqA: undetectable	3u5kD-2vgqA: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	ALA A 231 TYR A 17 TYR A 210 ASN A 234 GLY A 228	None None None SO4 A1467 (-3.5A) None	1.37A	3vwqA-2vgqA: undetectable	3vwqA-2vgqA: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWR_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 11	ALA A 231 ASP A 296 TYR A 210 ASN A 234 GLY A 228	None None None SO4 A1467 (-3.5A) None	1.30A	3vwrA-2vgqA: undetectable	3vwrA-2vgqA: 22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	GLU A 308 ASP A 314 ASP A 287 ASN A 294	None	1.41A	3vywD-2vgqA: undetectable	3vywD-2vgqA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A9J_A_TYLA1188_1 (BROMODOMAIN CONTAINING 2)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.65A	4a9jA-2vgqA: undetectable	4a9jA-2vgqA: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A9J_B_TYLB1187_1 (BROMODOMAIN CONTAINING 2)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.61A	4a9jB-2vgqA: 2.9	4a9jB-2vgqA: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A9J_C_TYLC1184_1 (BROMODOMAIN CONTAINING 2)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.68A	4a9jC-2vgqA: undetectable	4a9jC-2vgqA: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKI_A_IMNA201_1 (TRANSTHYRETIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	3 / 3	LYS A 142 LEU A 139 ALA A 141	None	0.66A	4ikiA-2vgqA: undetectable	4ikiA-2vgqA: 14.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KCN_A_MTLA804_0 (NITRIC OXIDE SYNTHASE, BRAIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	ARG A 433 ARG A 406 ASP A 407 ARG A 410	SO4 A1465 ( 2.4A) None None SO4 A1465 (-4.6A)	1.22A	4kcnA-2vgqA: undetectable	4kcnA-2vgqA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KCN_B_MTLB805_0 (NITRIC OXIDE SYNTHASE, BRAIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	ARG A 433 ARG A 406 ASP A 407 ARG A 410	SO4 A1465 ( 2.4A) None None SO4 A1465 (-4.6A)	1.20A	4kcnB-2vgqA: undetectable	4kcnB-2vgqA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LZR_A_LOCA201_1 (BROMODOMAIN-CONTAINI NG PROTEIN 4)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 8	VAL A 391 LEU A 453 LEU A 445 ILE A 381	None	0.83A	4lzrA-2vgqA: undetectable	4lzrA-2vgqA: 15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 5	ASN A 267 ALA A 51 GLY A 56 ASP A 14	None None None MTT A1463 (-2.9A)	0.96A	4n48A-2vgqA: undetectable	4n48A-2vgqA: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 9	ALA A 264 ALA A 105 LEU A 103 LEU A 262 VAL A 261	None	1.13A	4or0B-2vgqA: undetectable	4or0B-2vgqA: 23.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJE_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	4 / 6	LEU A 304 ILE A 329 THR A 93 MET A 321	None	1.31A	5ljeA-2vgqA: undetectable	5ljeA-2vgqA: 12.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	6 / 12	ALA A 342 ALA A 338 GLY A 166 ALA A 188 PHE A 169 VAL A 181	None	1.40A	5w4zA-2vgqA: undetectable	5w4zA-2vgqA: 9.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	6 / 12	ALA A 342 ALA A 338 GLY A 166 ALA A 188 PHE A 169 VAL A 181	None	1.42A	5w4zB-2vgqA: undetectable	5w4zB-2vgqA: 9.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BM5_A_SAMA1301_0 (METHIONINE SYNTHASE)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 11	PRO A 133 GLU A 130 PRO A 254 ALA A 163 PRO A 159	None	1.45A	6bm5A-2vgqA: undetectable	6bm5A-2vgqA: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECX_A_SAMA1301_0 (STIE PROTEIN)	2vgq	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIA L ANTIVIRAL-SIGNALING PROTEIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A 275 GLY A 24 VAL A 35 LEU A 7 ILE A 9	None	0.97A	6ecxA-2vgqA: undetectable	6ecxA-2vgqA: 21.76

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A   8;VAL A  50;ILE A  60;ASN A 267","None","0.94A","1e06A-2vgqA:undetectable","1e06A-2vgqA:15.61"],["2AOH_C_FRDC305_2","POL POLYPROTEIN;PEPTIDE INHIBITOR","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"LEU A 262;GLY A 289;ALA A 109;ILE A 108","None","0.86A","2aohB-2vgqA:undetectable","2aohB-2vgqA:13.24"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 264;LEU A 280;PHE A 279;VAL A 293;GLY A  16","None","1.09A","2ve3A-2vgqA:undetectable","2ve3A-2vgqA:20.91"],["2ZW9_A_SAMA801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"THR A  93;LEU A 285;ASP A 287;GLU A 111","None;None;None;MTT A1463 (-2.9A)","1.02A","2zw9A-2vgqA:undetectable","2zw9A-2vgqA:21.54"],["3A35_A_RBFA191_1","LUMAZINE PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"LEU A 192;THR A 193;ALA A 346;THR A 345;ILE A 348","None","1.21A","3a35A-2vgqA:undetectable","3a35A-2vgqA:15.77"],["3A35_B_RBFB191_1","LUMAZINE PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"LEU A 192;THR A 193;ALA A 346;THR A 345;ILE A 348","None","1.22A","3a35B-2vgqA:undetectable","3a35B-2vgqA:15.77"],["3A3B_A_RBFA191_1","LUMAZINE PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"LEU A 192;THR A 193;ALA A 346;THR A 345;ILE A 348","None","1.23A","3a3bA-2vgqA:undetectable","3a3bA-2vgqA:15.77"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"PHE A 258;ALA A 162;LEU A 247;PRO A 159","None","0.92A","3bgdA-2vgqA:undetectable","3bgdA-2vgqA:20.53"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 110;GLY A 300;PRO A 229;LYS A 305","None","0.72A","3bjwC-2vgqA:undetectable","3bjwC-2vgqA:13.15"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",12,"ASP A  14;LYS A  15;LYS A  42;GLU A  44;GLU A  45;ALA A  63;ASP A  65;ARG A  66;GLU A 111;PRO A 154;TRP A 230;TYR A 341","MTT A1463 (-2.9A);MTT A1463 (-2.7A);MTT A1463 (-4.3A);MTT A1463 (-3.1A);MTT A1463 (-3.5A);MTT A1463 (-3.2A);MTT A1463 (-2.8A);MTT A1463 (-3.7A);MTT A1463 (-2.9A);MTT A1463 (-3.5A);MTT A1463 (-4.4A);MTT A1463 (-4.5A)","0.23A","3jyrA-2vgqA:63.1","3jyrA-2vgqA:79.59"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",7,"ASN A  12;TRP A  62;GLU A 153;TYR A 155;MET A 330;TRP A 340;ARG A 344","MTT A1463 ( 4.8A);MTT A1463 (-4.2A);MTT A1463 (-3.1A);MTT A1463 (-3.7A);MTT A1463 ( 4.4A);MTT A1463 (-3.9A);MTT A1463 (-3.5A)","0.14A","3jyrA-2vgqA:63.1","3jyrA-2vgqA:79.59"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"VAL A 196;LEU A 160;GLY A 187;ALA A 188;LEU A 361","None","1.00A","3n8yB-2vgqA:undetectable","3n8yB-2vgqA:20.84"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"PHE A 156;GLY A 300;LEU A 299;GLU A 111;ALA A 231","MTT A1463 (-4.9A);None;None;MTT A1463 (-2.9A);None","0.85A","3tbgB-2vgqA:undetectable","3tbgB-2vgqA:21.55"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"PHE A 156;GLY A 300;LEU A 299;GLU A 111;ALA A 231","MTT A1463 (-4.9A);None;None;MTT A1463 (-2.9A);None","0.84A","3tbgD-2vgqA:undetectable","3tbgD-2vgqA:21.55"],["3U5K_A_08JA1_1","BROMODOMAIN-CONTAINING PROTEIN 4","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.69A","3u5kA-2vgqA:undetectable","3u5kA-2vgqA:14.01"],["3U5K_B_08JB2_1","BROMODOMAIN-CONTAINING PROTEIN 4","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.54A","3u5kB-2vgqA:undetectable","3u5kB-2vgqA:14.01"],["3U5K_C_08JC3_1","BROMODOMAIN-CONTAINING PROTEIN 4","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.64A","3u5kC-2vgqA:undetectable","3u5kC-2vgqA:14.01"],["3U5K_D_08JD4_1","BROMODOMAIN-CONTAINING PROTEIN 4","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.72A","3u5kD-2vgqA:undetectable","3u5kD-2vgqA:14.01"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 231;TYR A  17;TYR A 210;ASN A 234;GLY A 228","None;None;None;SO4 A1467 (-3.5A);None","1.37A","3vwqA-2vgqA:undetectable","3vwqA-2vgqA:22.69"],["3VWR_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 231;ASP A 296;TYR A 210;ASN A 234;GLY A 228","None;None;None;SO4 A1467 (-3.5A);None","1.30A","3vwrA-2vgqA:undetectable","3vwrA-2vgqA:22.31"],["3VYW_D_SAMD401_1","MNMC2","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"GLU A 308;ASP A 314;ASP A 287;ASN A 294","None","1.41A","3vywD-2vgqA:undetectable","3vywD-2vgqA:20.89"],["4A9J_A_TYLA1188_1","BROMODOMAIN CONTAINING 2","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.65A","4a9jA-2vgqA:undetectable","4a9jA-2vgqA:16.58"],["4A9J_B_TYLB1187_1","BROMODOMAIN CONTAINING 2","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.61A","4a9jB-2vgqA:2.9","4a9jB-2vgqA:16.58"],["4A9J_C_TYLC1184_1","BROMODOMAIN CONTAINING 2","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.68A","4a9jC-2vgqA:undetectable","4a9jC-2vgqA:16.58"],["4IKI_A_IMNA201_1","TRANSTHYRETIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",3,"LYS A 142;LEU A 139;ALA A 141","None","0.66A","4ikiA-2vgqA:undetectable","4ikiA-2vgqA:14.00"],["4KCN_A_MTLA804_0","NITRIC OXIDE SYNTHASE, BRAIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"ARG A 433;ARG A 406;ASP A 407;ARG A 410","SO4 A1465 ( 2.4A);None;None;SO4 A1465 (-4.6A)","1.22A","4kcnA-2vgqA:undetectable","4kcnA-2vgqA:20.63"],["4KCN_B_MTLB805_0","NITRIC OXIDE SYNTHASE, BRAIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"ARG A 433;ARG A 406;ASP A 407;ARG A 410","SO4 A1465 ( 2.4A);None;None;SO4 A1465 (-4.6A)","1.20A","4kcnB-2vgqA:undetectable","4kcnB-2vgqA:20.63"],["4LZR_A_LOCA201_1","BROMODOMAIN-CONTAINING PROTEIN 4","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"VAL A 391;LEU A 453;LEU A 445;ILE A 381","None","0.83A","4lzrA-2vgqA:undetectable","4lzrA-2vgqA:15.96"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"ASN A 267;ALA A  51;GLY A  56;ASP A  14","None;None;None;MTT A1463 (-2.9A)","0.96A","4n48A-2vgqA:undetectable","4n48A-2vgqA:20.54"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"ALA A 264;ALA A 105;LEU A 103;LEU A 262;VAL A 261","None","1.13A","4or0B-2vgqA:undetectable","4or0B-2vgqA:23.72"],["5LJE_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",4,"LEU A 304;ILE A 329;THR A  93;MET A 321","None","1.31A","5ljeA-2vgqA:undetectable","5ljeA-2vgqA:12.71"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",6,"ALA A 342;ALA A 338;GLY A 166;ALA A 188;PHE A 169;VAL A 181","None","1.40A","5w4zA-2vgqA:undetectable","5w4zA-2vgqA:9.57"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",6,"ALA A 342;ALA A 338;GLY A 166;ALA A 188;PHE A 169;VAL A 181","None","1.42A","5w4zB-2vgqA:undetectable","5w4zB-2vgqA:9.57"],["6BM5_A_SAMA1301_0","METHIONINE SYNTHASE","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"PRO A 133;GLU A 130;PRO A 254;ALA A 163;PRO A 159","None","1.45A","6bm5A-2vgqA:undetectable","6bm5A-2vgqA:23.58"],["6ECX_A_SAMA1301_0","STIE PROTEIN","2vgq","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN","Escherichia coli;Homo sapiens",5,"LEU A 275;GLY A  24;VAL A  35;LEU A   7;ILE A   9","None","0.97A","6ecxA-2vgqA:undetectable","6ecxA-2vgqA:21.76"]]